Last reviewed · How we verify
amnion chorion allograft membrane
At a glance
| Generic name | amnion chorion allograft membrane |
|---|---|
| Also known as | BioXclude™,Snoasis Medical products, USA. |
| Sponsor | Cairo University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Cellulitis
- Diabetic Foot Infection
Key clinical trials
- A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers (NA)
- Evaluation of the Safety and Efficacy of Dehydrated Human Amnion-Intermediate-Chorion Membrane (dHAICM) Allograft vs Standard of Care in the Treatment of Partial Thickness Thermal Burns (PHASE4)
- Evaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound Healing
- Regenerative Outcomes for Peri-implant Bony Defects Using Amnion-chorion Barrier vs. Collagen Membrane (NA)
- Nonhealing Venous Leg Ulcers Treated With a Standard of Care (SoC) Alone or Standard of Care and Dehydrated Human Placenta Tissue (dHPT) With Crossover (PHASE4)
- The Role of Amnion Membrane Allografts in Nipple Preservation (NA)
- CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations (NA)
- Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- amnion chorion allograft membrane CI brief — competitive landscape report
- amnion chorion allograft membrane updates RSS · CI watch RSS
- Cairo University portfolio CI